Ticker Scorecard - AMGN Basics Company: Amgen Inc. IPO Date: January 2, 1990 Sector: Healthcare Industry: Biotech Market Cap: $155.04B Activated in VL: True Average Daily Range Avg Daily Range: $1.33 | 0.98% Avg Daily Range (30 D): $2.46 | 0.91% Avg Daily Range (90 D): $2.97 | 1.01% Institutional Daily Volume Avg Daily Volume: 4.88M Avg Daily Volume (30 D): 2.34M Avg Daily Volume (90 D): 2.28M Trade Size Avg Trade Size (Sh.): 137 Avg Trade Size (Sh.) (30 D): 47 Avg Trade Size (Sh.) (90 D): 45 Institutional Trades Total Inst.Trades: 112,196 Avg Inst. Trade: $6.01M Avg Inst. Trade (30 D): $29.77M Avg Inst. Trade (90 D): $28.49M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 20 Market Closing Trades Avg Closing Trade: $62.14M Avg Closing Trade (30 D): $170.43M Avg Closing Trade (90 D): $156.48M Avg Closing Volume: 382.88K     News Feb 4, 2025 @ 4:00 PM Aplastic Anemia Global Clinical Trials Review 2024... Source: Na Jan 31, 2025 @ 2:00 PM Recombinant Chemicals Market to Reach US$ 6.7 Bn b... Source: Transparency Market Research Inc. Jan 27, 2025 @ 3:49 PM Biological Drugs Strategic Research Report 2024-20... Source: Na Jan 25, 2025 @ 11:17 AM These Were the 5 Worst-Performing Stocks in the Do... Source: The Motley Fool Jan 23, 2025 @ 12:51 PM Delta-like Ligand 3 (DLL3) Targeted Therapies Mark... Source: Researchandmarkets.Com Financials   TTM Q3 2024 Q2 2024 Basic EPS $7.89 $5.27 $1.39 Diluted EPS $7.83 $5.22 $1.38 Revenue $ 32.53B $ 8.5B $ 8.39B Gross Profit $ 19.68B $ 5.19B $ 5.15B Net Income / Loss $ 4.23B $ 2.83B $ 746M Operating Income / Loss $ 6.22B $ 2.05B $ 1.91B Cost of Revenue $ 12.86B $ 3.31B $ 3.24B Net Cash Flow $ -25730M $ -290M $ -407M PE Ratio 36.72